In addition to JPH-203, other drugs currently in preclinical and clinical trials targeting LAT1 include IPA-131, QBS-10072S, TLX101-CDx, 124I-ACD-101, 211At-TLX-102, OKY-034, [18F] NKO-028 (Table 1)
Oudit [email protected] Specialty Section: This article was submitted to General Cardiovascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
How Many Times a Day Should I Use Glutathione Serum
Our experienced team led by Nurse Practitioner Donna Burton ensures a comfortable and effective experience, leaving you feeling revitalized and ready to take on the day
Few significant associations between the intake of RF and the risk of ovarian cancer were observed [63]
Sep 2020;61(9):529-540